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Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal-recessive disorder, characterized by oto-sino-pulmonary dis-
ease and situs abnormalities. PCD-causing mutations have been identified in 20 genes, but collectively they account for only ~65% of all
PCDs. To identify mutations in additional genes that cause PCD, we performed exome sequencing on three unrelated probands with
ciliary outer and inner dynein arm (ODAþIDA) defects. Mutations in SPAG1 were identified in one family with three affected siblings.
Further screening of SPAG1 in 98 unrelated affected individuals (62 with ODAþIDA defects, 35 with ODA defects, 1 without available
ciliary ultrastructure) revealed biallelic loss-of-function mutations in 11 additional individuals (including one sib-pair). All 14 affected
individuals with SPAG1 mutations had a characteristic PCD phenotype, including 8 with situs abnormalities. Additionally, all individ-
uals with mutations who had defined ciliary ultrastructure had ODAþIDA defects. SPAG1 was present in human airway epithelial cell
lysates but was not present in isolated axonemes, and immunofluorescence staining showed an absence of ODA and IDA proteins in cilia
from an affected individual, thus indicating that SPAG1 probably plays a role in the cytoplasmic assembly and/or trafficking of the
axonemal dynein arms. Zebrafish morpholino studies of spag1 produced cilia-related phenotypes previously reported for PCD-causing
mutations in genes encoding cytoplasmic proteins. Together, these results demonstrate that mutations in SPAG1 cause PCD with ciliary
ODAþIDA defects and that exome sequencing is useful to identify genetic causes of heterogeneous recessive disorders.Primary ciliary dyskinesia (PCD) is a rare autosomal-
recessive disorder (MIM 244400) that results from genetic
abnormalities of motile cilia.1–3 Disease manifestations
include neonatal respiratory distress, chronic sino-
pulmonary disease, otitis media, male infertility, and
laterality defects in ~50% of affected individuals. PCD
is highly genetically heterogeneous, and mutations in
20 genes account for ~65% of cases.2–16 Most of the
genes implicated in PCD encode components of the
ciliary axonemal structure, including the outer and
inner dynein arms (ODAs and IDAs, respectively),
which are multiprotein complexes essential for ciliary
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The AmericFor PCD cases with absence of both the ODA and IDA,
mutations have been described in five genes involved in
cytoplasmic assembly of dynein arms:DNAAF1 (previously
LRRC50 [MIM 613190]), DNAAF2 (previously KTU [MIM
612517]), DNAAF3 (previously PF22 [MIM 614566]),
HEATR2 (MIM 614864), and LRRC6 (MIM 614930).11–16
The absence of both ODA and IDA occurs in as many as
30% of the ciliary ultrastructural defects in PCD, but
only a minority are caused by mutations in the five genes
involved in cytoplasmic assembly of dynein arms.11–16
Given this heterogeneity, we sought to identify additional
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PCD with ODAþIDA defects (Table S1 available online, de-
mographic and clinical phenotype). Study participants
were recruited at the UNC and collaborating sites of Ge-
netic Disorders of Mucociliary Clearance Consortium and
signed informed consents were obtained. The study was
approved by the institutional review board for the Protec-
tion of the Rights of Human subjects at the UNC and
collaborating institutions.
Exome sequencing was performed as previously
described.9,17 In brief, sheared genomic DNA was ligated
to sequencing adaptors bearing an 8 bp barcode, followed
by PCR amplification and hybridization-based, solution-
phase capture with EZSeqCap V1 (corresponding to
CCDS2008 gene set) probes (Roche Nimblegen). Posten-
richment libraries were amplified, pooled, and sequenced
on an Illumina GAIIx (PE76 þ barcode read). After bar-
code-based sample deconvolution, sequence reads were
mapped with BWA to the reference human genome
(UCSC Genome Browser hg18).18 On average, we achieved
763mean fold coverage of the targeted exome (26.4 meg-
abases [Mb]), with 98% covered at R83 (details in Table
S2). SAMtools were used for sequence variant calling after
removal of potential PCR duplicates, with a minimum
quality threshold of 30 for SNPs and 200 for indels.19
Average calls per individuals were 17,553 base substitu-
tions and 504 insertions and/or deletions (Table S2), and
SeattleSeq server was used for genotype annotation (Table
S3). After removal of common variants as previously
described,9 only genes with biallelic variants consistent
with an autosomal-recessive model were considered
further (Tables S2 and S3). Variants were prioritized for vali-
dation by Sanger sequencing (capillary electrophoresis;
Life Technologies) based on manual investigation of their
pathogenic potential, their expression in ciliated airway
epithelia (RNA-seq data set, unpublished), their potential
relevance to PCD through published literature, and anal-
ysis of large-scale coexpression data sets.20,21 The results
of validations and the primer sequences are presented in
Tables S3 and S4. Segregation analysis of the confirmed var-
iants in the proband was carried out on the available DNA
from family members.
We identified an apparently homozygous missense
variant of the start codon (c.2T>G [p.Met1?]) in exon 2 of
SPAG1 (sperm-associated antigen 1, RefSeq accession num-
ber NM_172218.2 [MIM 603395]) in an individual with
PCD (#711 [III-2]) and ODAþIDA defects in ciliary
ultrastructure (Table 1). This variant in the translation start
site is predicted to abrogate SPAG1 protein translation.
Sanger sequencing confirmed the mutation in a heterozy-
gous state in the unaffected mother (#713 [II-2]) but failed
for the unaffected father (#713 [II-1]), which prompted us
to consider the possibility of a large deletion in this region
of SPAG1 encompassing the start codon. Intragenic high-
frequency SNPs were genotyped in this propositus with
PCD (#711 [III-2]) and his unaffected father (#713 [II-1])
by means of 17 primer pairs (Table S4) across SPAG1, plus
two adjacent genes, FBXO43 (MIM 609110) and POLR2K712 The American Journal of Human Genetics 93, 711–720, October(MIM 606033) (Figure 1A). The genotyping revealed loss
of heterozygosity encompassing the C terminus of POLR2K
and the N terminus of SPAG1 as well as intergenic se-
quences between these genes (Figure 1A and Table S5).
Amplification by long-range PCR coupled with Sanger
sequencing identified the deletion breakpoint leading
to an 11,971 bp deletion (c.61þ201_POLR2K:
c.140þ1169_SPAG1del) in the affected propositus (#711
[III-2]) and his unaffected father (#713 [II-1]) (Figures 1A,
1B, and S1A). This deletion encompassed the stop codon
and 30 UTR of POLR2K, the 50 UTR and start codon of
SPAG1, and intergenic sequences and is predicted to abro-
gate protein translation for SPAG1. Subsequently, a PCR-
based assay was developed to detect this large deletion
(Figure S1B). This deletion analysis, coupled to Sanger
sequencing, confirmed recessive inheritance of the start
codon variant (c.2T>G [p.Met1?]) and deletion in the pro-
positus (#711 [III-2]) and two affected siblings (#710 [III-1]
and #712 [III-3]) (Table 1 and Figure 1B). Because the large
deletion on one allele led to a loss-of-function mutation
in POLR2K, we performedmutation analysis in the propos-
itus (#711 [III-2]); however, no other mutations were iden-
tified in POLR2K, suggesting that mutations in SPAG1 are
indeed responsible for the PCD phenotype. The concept
that mutations in SPAG1 (and not POLR2K) cause PCD is
because (1) only one mutant allele in POLR2K does not
explain the autosomal-recessive inheritance of PCD, (2)
functional data from zebrafish (see below) show that
SPAG1 is important for cilia function, and (3) PCDoccurred
in seven unrelated individuals who had biallelic mutations
in SPAG1 but did not have the POLR2K deletion. Addition-
ally, SPAG1 is a strong candidate because analysis of the
gene expression data set (UGET) showed coordinate regula-
tion between SPAG1 and multiple other genes known to
harbor PCD-causing mutations;20,21 plus SPAG1 has never
been implicated with any other inherited disorders.
We sought to identify additional cases of PCD with bial-
lelic mutations in SPAG1 by testing 62 affected individuals
with similar ultrastructural findings as our SPAG1 discov-
ery case (ODAþIDA defects), another cohort of 35 affected
individuals with isolated ODA defects, and a singleton case
with unknown ciliary ultrastructure. A combination of
methods were used to test SPAG1 in these 98 individuals,
including screening for the large deletion (Figure S1B) in
all cases, Sanger-based high-throughput sequencing
through the Genotyping and Resequencing Services in Se-
attle (RC2-HL-102923) or at UNC via capillary electropho-
resis ([Life Technologies], primer sequences shown in Table
S4) (89 unrelated cases), and additional whole-exome
sequencing and targeted screening for SPAG1 (nine unre-
lated cases) (Table S6).9,22 Full details of the exomes for
six individuals with ODA defects is described in Knowles
et al.9 (subjects 144, 359, 453, 483, 961, and 980) and
two individuals with ODAþIDA defects are described in
Zariwala et al.22 (subjects A4207 and A4218), and one indi-
vidual (#1802 [II-1]) with ODAþIDA defects harboring
biallelic mutations in SPAG1 is listed in Table 1.3, 2013
Table 1. Demographic, Clinical Phenotype, and SPAG1 Mutations in 14 PCD-Affected Subjects from 11 Unrelated Families
Subject # Family # Sex
Age
in
Years
Situs
Status
Ciliary
Ultrastructural
Defect Ethnicity
nNO
nl/mina
Neo
RDS Bxsis Sinusitis
Otitis
Media
Allele 1 Allele 2
Exon #
Base
Change
Amino
Acid
Change Segregationb Exon #
Base
Change
Amino
Acid
Change Segregationb
Homozygous Mutations
OP-94 (II-2) OP94 F 17 SS ODAþIDA white NA NA NA yes yes 7 c.679G>T p.Glu227* paternal 7 c.679G>T p.Glu227* maternal
#1854 (II-1) UNC-608 F 4 mo SI ODAþIDA white 9.4 yes no yes yes 9 c.902_906
delAAGTA
p.Lys301
Thrfs*4
paternal 9 c.902_906
delAAGTA
p.Lys301
Thrfs*4
maternal
OP-16 (II-1)c,d OP16 M 35 SI ODAþIDA white NA yes yes yes no 16 c.2014C>T p.Gln672* paternal 16 c.2014C>T p.Gln672* maternal
OP-46 (II-1) OP46 M 14 SI ODAþIDA NA NA NA yes yes yes 16 c.2014C>T p.Gln672* NA 16 c.2014C>T p.Gln672* NA
#1391 (III-1) UNC-372 M 5 SI ODAþIDA white 11.3 yes NA yes yes 16 c.2014C>T p.Gln672* paternal 16 c.2014C>T p.Gln672* maternal
#1802 (II-1)c UNC-587e M 14 SI ODAþIDA South
Asian
107.2 yes no no no 18 c.2542delG p.Asp848
Ilefs*10
NA 18 c.2542delG p.Asp848
Ilefs*10
NA
#1803 (II-2)c UNC-587e M 2 SI ODAþIDA South
Asian
8.8 no no no yes 18 c.2542delG p.Asp848
Ilefs*10
NA 18 c.2542delG p.Asp848
Ilefs*10
NA
Compound Heterozygous Mutations
#710 (III-1) UNC-121e M 12 SS ODAþIDA white 41.1 yes yes yes yes multif large
deletionf
untranslated paternal 2 c.2T>G p.Met1?g maternal
#711 (III-2) UNC-121e M 10 SI ODAþIDA white 13.1 yes no yes yes multif large
deletionf
untranslated paternal 2 c.2T>G p.Met1?g maternal
#712 (III-3) UNC-121e F 8 SS ODAþIDA white 14.6 yes no yes yes multif large
deletionf
untranslated paternal 2 c.2T>G p.Met1?g maternal
OP-13 (II-2) OP13 M 19 SS ODAþIDA white NA no yes yes NA multif large
deletionf
untranslated maternal 16 c.2014C>T p.Gln672* paternal
OP-90 (II-2) OP90 M 22 SI ODAþIDA white NA yes yes yes yes multif large
deletionf
untranslated paternal 16 c.2014C>T p.Gln672* maternal
#26 (II-1) UNC-4 F 16 SI NA white NA yes yes yes yes multif large
deletionf
untranslated maternal 16 c.2089C>T p.Arg697* paternal
#2103 (II-1) UNC-712 F 12 SS ODAþIDA white 1.0 yes NA yes yes 9 c.902_906
delAAGTA
p.Lys301
Thrfs*4
NA 16 c.1993_1996
delCTCT
p.Leu665
Valfs*3
NA
Abbreviations are as follows: M, male; F, female; SI, situs inversus; SS, situs solitus; NA, not available; ODAþIDA, outer þ inner dynein arms; Neo RDS, neonatal respiratory distress in full-term neonates; Bxsis, bronchiectasis;
nNO, nasal nitric oxide.
aNormal nNO levels are 3765 124 nl/min (mean 5 SD), calculated from 27 healthy subjects.5
bMutant allele shown to segregate with either the paternal or maternal side of the family (pedigrees in Figures 1 and S2).
cParental consanguinity was noted.
dFamily was linked to SPAG1 locus.
eAffected siblings are listed under same family numbers.
fLarge 11,971 bp deletion (c.61þ201_POLR2K:c.140þ1169_SPAG1del) comprised of multiple introns, exons, and untranslated regions from 30 of POLR2K and 50 of SPAG1. This deletion includes translation start codon and is
predicted to abrogate SPAG1 translation.
gBase substitution leading to apparent missense mutation in the translation start codon is predicted to abrogate SPAG1 translation.
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Figure 1. Deletion Analysis in SPAG1, Segregation of Mutations in Pedigrees, and Ciliary Ultrastructural Defects
(A) A total of 17 primer pairs (see the arrows; listed in Table S4 as SPAG1 exons 1, 2, 3, 5, 7, 15, 18, 19, introns 1-1, 1-2, 4-1, 4-2, POLR2K
exons 1, 3, 30 UTR, FBXO43 exons 1 and 3) were designed for SNP genotyping to ascertain loss of heterozygosity in affected individual
(#711 [III-2] from family UNC-121). Genomic structure and coordinates for FBXO43, POLR2K, and SPAG1 are shown. Filled boxes desig-
nate exons (E), horizontal lines designate introns (IVS), and location of 50 UTR, 30 UTR, translation start and stop, and intergenic se-
quences are shown. Introns and exons are not drawn to scale. Absence of paternal alleles from affected individual at certain loci is shown
with the red arrows for primers. The exact genotype is presented in Table S5.
(B–D) Pedigrees with mutations segregating in trans, consistent with autosomal-recessive mode of inheritance (see additional pedigrees
in Figure S2). Males and females are designated by squares and circles, respectively. Filled symbols indicate affected individuals with PCD
and symbols with a dot within indicate carrier status. Proband is designated by an arrow, presence of parental consanguinity is desig-
nated by double horizontal lines between the parents, and SI refers to situs inversus. Shown are families UNC-121 (B), UNC-372 (C),
and UNC-587 (D).
(E) Normal ciliary ultrastructure from healthy subject (left) and individual (#1803 [II-2] of family UNC-587) with biallelic mutations in
SPAG1 with defective outerþinner dynein arms (middle) and/or stubs (right) (see arrows).All variants were confirmed by Sanger sequencing at
UNC. We identified biallelic mutations in an additional
11 individuals (10 unrelated families) (Table 1); thus, bial-
lelic mutations in SPAG1 were found in a total of 11 fam-
ilies (14 affected individuals), and segregation analysis
confirmed that the mutations were inherited in trans in
the 8 families that could be tested, consistent with reces-
sive inheritance (Figures 1B–1D and S2). All 13 subjects
with defined ciliary ultrastructure had ODAþIDA defects
(Figures 1E). The clinical phenotypes of all individuals
with biallelic mutations (Table 1) were indistinguishable
from individuals with ‘‘classic’’ PCD with ODA defects
and mutations in DNAI1 (MIM 604366) or DNAH5 (MIM
603335), including situs inversus and low levels of nasal
nitric oxide (nNO).23–26 Videomicroscopy was carried out
to explore the functional consequences of biallelic muta-714 The American Journal of Human Genetics 93, 711–720, Octobertions in SPAG1 on respiratory cilia obtained from two
affected individuals (#712 [III-3] UNC-121 and #1391
[II-1] UNC-372). Consistent with ODAþIDA defects, cilia
exhibited near complete ciliary immotility (Movies S1,
S2, and S3).
The genomic organization of SPAG1 and location of
mutations is shown in Figure 2. SPAG1 consists of 18 cod-
ing exons and encodes a large protein with 926 amino acid
residues (Figures 2 and S3). SPAG1 contains nine tetratrico-
peptide repeat motifs (TPRs) that form scaffolds to mediate
protein-protein interactions and are often involved in the
assembly of multiprotein complexes (Figure S3).27 In total,
there were eight different mutant alleles (three frameshift,
three nonsense, one large deletion, and one missense or
null at the start codon), and all mutant alleles are predicted
to lead to loss of function of full-length SPAG1 (Table 1 and3, 2013
Figure 2. Genomic Organization of SPAG1 and Location of PCD-Causing Mutations
(A) The transcript of SPAG1 consists of 3,760 bp (RefSeq NM_172218.2). Filled boxes designate exons (E), horizontal lines designate in-
trons (IVS), and locations of 50 UTR, 30 UTR, start and stop codons, and noncoding exon 1 are shown. Introns and exons are not drawn to
scale. The positions of all eight identified SPAG1 putative mutations are indicated.
(B) Large 11,971 bp deletion involves deletion of part of intron 2 and upstream regions including start codon of SPAG1 as well as 30 region
of the proximal gene POLR2K that include stop codon. Precise breakpoints (dashed vertical lines) and the nucleotide sequence of the
junction point, includingmicrohomology (underlined) at the breakpoint, are shown. For the mutation nomenclature, the microhomol-
ogy region is included in POLR2K. Deletion breakpoint sequence in an affected individual is shown with the vertical dotted line.
(C) Hemizygous mutation in affected (top), heterozygous carrier (middle), and hemizygous wild-type (bottom) for start codon c.2T>G
(p.Met1?) mutation sequences.
(D and E) Homozygous mutation in affected (top) and heterozygous carrier (middle) individuals and corresponding wild-type sequences
in control (bottom) individual for c.679G>T (p.Glu227*) (D) and c.2014C>T (p.Gln672*) (E) mutations.
(F) Homozygous mutation in affected (top) and corresponding wild-type sequences in control (bottom) individuals for
c.2542delG (p.Asp848Ilefs*10) mutation.
(G and H) Heterozygous mutation in affected (top) and corresponding wild-type sequence (bottom) in controls for c.2089C>T
(p.Arg697*) (G) and c.1993_1996delCTCT (p.Leu665Valfs*3) (H) mutations.
(I) Homozygous mutation in affected (top) and heterozygous mutation in another affected (middle) and corresponding wild-type
sequences in control (bottom) individuals for c.902_906delAAGTA (p.Lys301Thrfs*4) mutation. Additionally, a polymorphism
c.897G>A (p.Leu299Leu) was noted that is listed in Table S7.
Base sequence, amino acid sequence, and codon numbers are shown. Location of the mutation is shown by filled diamond andmutated
amino acids are represented by red fonts. Pedigrees and segregation analysis are shown in Figures 1 and S2.Figure 2). Five of the eight mutant alleles were private;
however, three alleles were seen to occur in more than
one unrelated families. The three recurrent mutant alleles
(c.2014C>T [p.Gln672*]; a large 11,971 bp deletion; and
c.902_906delAAGTA [p.Lys301Thrfs*4]) were seen in five,
four, and two unrelated families, respectively. For subjects
harboring the three recurrent mutant alleles, we con-
structed haplotypes for all variants and polymorphisms
detected during Sanger sequencing of SPAG1. We found
that all affected individuals carried an identical haplotype
in cis with the c.2014C>T (p.Gln672*) mutation, an iden-The Americtical haplotype in cis with the large deletion, and an
identical haplotype in cis with the c.902_906delAAGTA
(p.Lys301Thrfs*4) mutation. These results suggest that
these three variants are founder mutations (Figure S4).
Mutation screening identified a large number of benign
variants in SPAG1 that are listed in Table S7. To further
investigate the role of SPAG1 in ciliary structure and func-
tion and in PCD, we examined its expression in a panel of
human tissues. At least two different SPAG1 proteins are
predicted (104 and 48 kDa);28,29 therefore, we designed
primers to amplify both a full-length (long) transcriptan Journal of Human Genetics 93, 711–720, October 3, 2013 715
Figure 3. Expression of SPAG1 and Morpholino Knockdown in Zebrafish
(A) Expression pattern of two SPAG1 transcripts in a panel of normal human tissues. Specific primers to the full-length (long) and trun-
cated transcripts (Table S4) were used for RT-PCR on total RNA from different tissues (Ambion, Life Technologies).
(B) Expression pattern of long and short forms of SPAG1 (top and second from top) during ciliogenesis in human airway cells. RNA was
isolated from human airway epithelial cells at different times after plating on collagen-coated culture inserts at an air-liquid interface.
Under these conditions the cells initially grow as a single mono-layer of undifferentiated ‘‘basal-like’’ cells. After 10–14 days, ciliated cells
begin to appear, increasing over the next 2–3 weeks before plateauing at approximately 60%–80%of the culture.30,31 For both expression
analyses, DNAI1 (third from top) was used as a known ciliary differentiation gene control and PPIA (cyclophilin A) (bottom) as a positive
RNA control. The full-length SPAG1 transcript is induced coordinately with ciliated cell differentiation.
(C) Immunoblot showing expression of SPAG1 (top) and DNAI1 (bottom) in undifferentiated and differentiated human airway epithelia
cells and isolated cilia. Total cell lysates and ciliary axonemes were isolated as previously described.33 DNAI1 is present in the ciliary
axoneme; SPAG1 is not.
(D and E) High-resolution immunofluorescence analysis of the localization of DNAH5 (D) and DNALI1 (E) in respiratory cells from a
control (top) and affected individual OP-94 (II-2) (bottom) carrying biallelic mutations in SPAG1. In control cells (top), axoneme-specific
acetylated alpha tubulin (green), DNAH5 (red), and DNALI1 (red) colocalizes to the entire length of the axonemes. The yellow immu-
nofluorescence in the ciliary axonemes indicates colocalization of both proteins in cilia of control. In contrast, in respiratory epithelial
cells from an affected individual, OP-94 (II-2) (bottom), DNAH5 and DNALI1 are completely missing from the ciliary axoneme. Nuclei
were stained with Hoechst 33342 (blue). Scale bars represent 10 mm.
(F) Knockdown of zebrafish ortholog of SPAG1, using splice blocking morpholino targeting splice acceptor site at the intron 4-exon 5
junction of zebrafish (50-TCTGGCTGTGGAGAAAGTAGATACA-30; QA accession # ZDB-GENE-030131-9443). Standard control morpho-
lino (50-CCTCTTACCTCAGTTACAATTTATA-30; Gene Tools LLC) was injected to zebrafish, as control. Unlike controls (left), spag1mor-
pholino-injected zebrafish show tail curls (right) 72 hr after injection. Hydrocephalus is indicated by an arrow (right).
(G) Quantification of the zebrafish phenotype data shows increased incidence of dorsal curvature (p¼ 0.00017 by t test) and hydroceph-
alus (p ¼ 0.00018 by t test); however, increase in incorrect heart looping (p ¼ 0.17 by t test) was not significant (actual values shown in
Table S8).
Error bars indicate51 SD from the mean of three replicates.and a shorter transcript containing only the first ten exons
(Ensembl; Table S4, Figure S3). Figure 3A demonstrates that
both SPAG1 transcripts were present in most tissues,
including lung, with the strongest expression in brain, co-
lon, kidney, and testis, in agreement with the EST data set.
To examine SPAG1 expression in human airway epithelial716 The American Journal of Human Genetics 93, 711–720, Octobercells, RNA was isolated from air-liquid interface cultures of
airway epithelia at different stages of differentiation and
examined by reverse transcriptase-polymerase chain reac-
tion (RT-PCR).30–32 Although the shorter SPAG1 transcript
was expressed in human airway epithelial cells at all time
points throughout the culture period, the full-length,3, 2013
longer transcript was strongly induced at later stages of cul-
ture, when ciliated cell differentiation was occurring
(Figure 3B). This induction closely paralleled the expres-
sion pattern for DNAI1, a known component of the ciliary
outer dynein arm, suggesting that the longer transcript of
SPAG1 plays a specific role in ciliated cells. Interestingly,
four of the eight mutant alleles would not be expected to
alter the protein predicted from the short transcript, again
suggesting that it is the longer, full-length SPAG1 that is
important to ciliated cell function. Spag1 is induced during
differentiation of mouse spermatogenic cells,28 and SPAG1
is expressed in human lung and testis (EST Profile Viewer
in EST database), consistent with a potential function in
ciliated cells.
A monoclonal antibody targeting the COOH region of
SPAG1 (kind gift of T. Crnogorac-Jurcevic29) (Figure S3)
reacted strongly with two proteins in immunoblots of total
cell lysates from fully ciliated cultures (Figure 3C) that were
not detected in lysates from undifferentiated cells, again
paralleling the expression of DNAI1. These proteins of
~92 and 105 kDa are close to the expected size predicted
for full-length SPAG1 (104 kDa) and may be the result of
an alternative splicing event or posttranslational modifica-
tion. In addition, the antibody detected a smaller protein
of ~50 kDa in immunoblots of total cell lysates from
both the undifferentiated and ciliated airway epithelia;
however, it is not clear whether this band represents an
additional form of SPAG1 or whether this signal is due to
cross-reactivity of the antibody. Interestingly, little or no
SPAG1 was detected in isolated ciliary axonemes
(Figure 3C), in contrast to the strong signal detected for
DNAI1.33 This result agrees with our earlier proteomic
analysis that did not identify SPAG1 as a component of iso-
lated ciliary axonemes,34 indicating that SPAG1 is prob-
ably not an integral axonemal protein but plays a role in
the cytoplasmic assembly of the ciliary dynein arms. To
better understand the effects of SPAG1 mutations at the
protein level, we performed immunofluorescence (IF) anal-
ysis in respiratory epithelia from the PCD individual (OP-
94 [II-2]) with biallelic mutations in SPAG1. The IF studies
were carried out with antibodies targeting the ODA heavy
chain, DNAH5, and the IDA light chain component,
DNALI1, as previously described.35,36 Both DNAH5 and
DNALI1 were completely absent from the ciliary axonemes
of this individual with PCD (Figures 3D and 3E), which is
consistent with the ciliary ultrastructural analyses. We
have previously shown that respiratory cilia have two
distinct ODA types: (1) a proximally located ODA type 1
containing DNAH5 and probably DNAH11 (DNAH9 is
absent) and (2) distally located ODA type 2 containing
DNAH5 and DNAH9.35 In SPAG1 mutant cilia, the IF anal-
ysis revealed absence of both ODA types (Figure 3D),
which is similar to findings reported for cytoplasmic
proteins involved in preassembly of cilia (DNAAF1/
LRRC50;13 DNAAF3;14 LRRC6 and ZMYND10 mutant
cilia22). Thus, SPAG1 is probably involved in similar cyto-
plasmic preassembly processes as these four proteins.The AmericThese findings differ from another cytoplasmic preassem-
bly protein DNAAF2 (KTU) mutant cilia, where only the
distal type 1 ODA is defective.15 The concept that SPAG1
is involved in preassembly of axonemal components is
further supported by the absence of the IDA component
DNALI1 in the axoneme of SPAG1 mutant cilia
(Figure 3E). SPAG1 mutant cilia are different when
compared to cilia with mutations in DNAH5, DNAI1,
DNAI2 (ODA components), and ARMC4 (targeting ODA
complexes), because these gene mutations cause isolated
ODA defects without affecting the localization of IDA pro-
tein DNALI1.7,37
The zebrafish (D. rerio) ortholog spag1 (ZFIN database
accession number ZDB-GENE-030131-9443) has 45%
identity to SPAG1 at the protein level. To directly test the
function of spag1 in zebrafish, antisense mopholinos, tar-
geting the splice acceptor site at the junction of intron 4
and exon 5, were injected into embryos. Knockdown effi-
ciency was confirmed by RT-PCR (data not shown). Mutant
zebrafish exhibited dorsal body axis curvature (75% versus
8% in control) and hydrocephalus (66% versus 3% in
control); however, heart looping defects showed only a
modest increase (8% versus 4% in control) that was not
significant (Figures 3F and 3G, Table S8). It is possible
that the use of a different morpholino, or a translation-
blocking morpholino, may show a significant increase in
incorrect heart looping, but that was not possible to design
because of the incomplete annotation of zebrafish spag1.
These cilia-related phenotypes have previously been noted
in several zebrafish models of PCD-causing mutations
in genes that encode cytoplasmic proteins, including
DNAAF3,14 LRRC50,38 and LRRC6.39,40
In the current study, three unrelated individuals
underwent exome sequencing as the initial cohort, which
led to the identification of mutations in SPAG1 in one
individual with PCD. For the remaining two individuals
with PCD and ODAþIDA defects who were exome
sequenced, one individual (#SL0018) harbored a homozy-
gous missense variant (c.2384C>T [p.Leu795Pro]) in
HEATR2 (RefSeq NM_017802.3) (Tables S1 and S2). This
individual belongs to a large Amish Mennonite cohort
with multiple PCD-affected individuals, and the genetic
and biological analysis of this missense mutation in
HEATR2 as a cause of PCD have been published.11 In
another individual (#158 [III-1]), contemporaneous studies
by the candidate gene approach identified biallelic muta-
tions in DYX1C1 (MIM 608706) (c.783þ1G>T and
3,549 bp deletion), and targeted sequencing reveals the
same genetic defects in an affected sibling (#159 [III-3])
as well.41 Further review of our exome genotype calls for
DYX1C1 revealed that indeed the splice mutation was an-
notated; however, a second mutant allele (large deletion)
was missed because of its size. Hence, our exome filtration
analysis that assumes a recessive trait for PCD failed to
identifyDYX1C1 as a potential candidate gene in this pedi-
gree. Interestingly, in addition to PCD, the proband (#158
[III-1]) also had an apparently autosomal-dominantan Journal of Human Genetics 93, 711–720, October 3, 2013 717
retinitis pigmentosa (AD-RP [MIM 268000]), and exome
data analysis identified a heterozygous nonsense mutation
(c.2515G>T [p.Glu839*]) in TOPORS (RefSeq
NM_005802.4 [MIM 609507]) that has previously been
implicated in AD-RP.42 This TOPORSmutation was not pre-
sent in the PCD-affected sibling (#159 [III-3]) who did not
have AD-RP, which revealed that AD-RP and PCD segregate
independently (Figure S5). Previously, cosegregation of
PCD and X-linked RP has been associated with the hemizy-
gous mutations in RPGR (MIM 312610).43–45 However, our
genetic analysis confirms that PCD and AD-RP in this fam-
ily are caused by mutations in different genes (Figure S5).
In conclusion, exome sequencing identified biallelic muta-
tions in SPAG1 that cause PCD with ODAþIDA defects
associated with severe ciliary dysmotility and laterality
defects. SPAG1 was not observed in isolated ciliary axo-
nemes and is probably involved in the cytoplasmic assem-
bly or transport of the dynein arm complexes. Of the eight
different mutant alleles identified in SPAG1, three were
seen in at least two unrelated families, and haplotype anal-
ysis suggests that these are founder mutations in individ-
uals with Northern European ancestry. Additionally, we
identified a nonsense mutation in TOPORS as a cause of
AD-RP. The identification of genetic causes of PCD in two
families and AD-RP in one family via exome sequencing
further demonstrates the power of this approach for iden-
tifying the molecular etiology in genetically heteroge-
neous disorders.Supplemental Data
Supplemental Data include Supplemental Acknowledgments, five
figures, eight tables, and three movies and can be found with this
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